Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Two-drug antibiotic for UTIs and pneumocystis. | First choice for simple bladder infections. |
| Body system | Antibiotics | Antibiotics |
| Drug class | Sulfonamide combinations | Nitrofurans |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Urinary tract infections, Pneumocystis pneumonia treatment and prevention, MRSA skin infections, Toxoplasmosis prevention | Uncomplicated cystitis, Preventing recurrent UTIs |
| How it works | Blocks two steps in the vitamin pathway bacteria depend on. | Builds up in urine and attacks bacteria there in several ways at once. |
| Starts working | — | — |
| Half-life | About 10 hours | About 20 minutes |
| Typical adult dose | 960 mg (800/160 mg) twice a day. | Modified-release 100 mg twice a day with food for 3 days (women) or 7 days (men). |
| Forms | Tablet, Oral suspension, IV infusion | Capsule, Modified-release capsule, Oral suspension |
| Common side effects | Nausea, Rash, Loss of appetite | Nausea, Headache, Dark yellow or brown urine |
| Serious side effects | Severe skin reactions (SJS/TEN), High potassium, Blood disorders, Kidney injury | Lung reactions (cough, breathlessness), Liver injury with long-term use, Nerve damage |
| Don't take if | Allergy to sulfonamides; Folate deficiency or blood disorders; Severe kidney or liver impairment; Late pregnancy, newborns under 6 weeks | Significantly reduced kidney function (eGFR below about 45); Allergy to nitrofurantoin; Last weeks of pregnancy and babies under 3 months; G6PD deficiency |
| Alcohol | Usually no problem in moderation. No direct interaction. | Usually no problem in moderation. No direct interaction. |
| Pregnancy | Usually avoidedAvoided in the first trimester (folate antagonist) and near term, except for HIV-related prevention. | Use with cautionFine in early and mid pregnancy; avoid near delivery (risk of anaemia in the baby). |
| Breastfeeding | Use with cautionAvoid in the first weeks after birth, and in G6PD-deficient infants. | Use with cautionAvoid in the first weeks after birth and in G6PD-deficient infants. |
| In use since | 1968 | 1953 |
| Brand names | United States: Bactrim, SeptraUnited Kingdom: SeptrinIndia: Septran, Bactrim | United States: Macrobid, MacrodantinUnited Kingdom: Macrobid, MacrodantinIndia: Niftran |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | J01EE01 | J01XE01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker